Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Head & Neck 1

Conditions

Breast Neoplasms 3Warts 2Neurofibromatosis 1 2Neoplasms 2Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Retinal Neoplasms 1Port-Wine Stain 1Pancreatic Neoplasms 1Osteoma, Osteoid 1Neurofibromatoses 1Neoplasm Metastasis 1Mucositis 1Lymphedema 1Keratosis, Actinic 1Hemangioma, Capillary 1Head and Neck Neoplasms 1Eye Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Bile Duct Neoplasms 1Atrophy 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Lasers × Clear all
NCT04081805 2025-04-24

EPMLARF

Federal University of São Paulo

Phase NA Active not recruiting
195 enrolled
Breast

Atrophy, Breast Neoplasms

NCT00852930 2017-04-11

Low Level Laser Treatment and Breast Cancer Related Lymphedema

Vanderbilt University

Phase 4 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Lymphedema

NCT01872923 2014-06-16

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

PCI Biotech AS

Phase 1 Completed
3 enrolled
BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡